Home » Topics » Regulatory

Regulatory
RSS

Febuxostat receives E.U. marketing authorization for hyperuricemia in gout

May 6, 2008

Sucampo obtains FDA approval for Amitiza for IBS with constipation in adult women

April 30, 2008

FDA approves Vyvanse to treat adult ADHD

April 25, 2008

Treximet receives FDA approval for acute treatment of migraine

April 17, 2008

Actemra approved in Japan to treat patients with rheumatoid arthritis

April 16, 2008

FDA approves Lexiscan as an agent in myocardial perfusion imaging

April 11, 2008

FDA approves Orencia for polyarticular juvenile idiopathic arthritis

April 9, 2008

Oncophage approved in Russia for intermediate-risk kidney cancer

April 9, 2008

Sinovac receives China's approval for pandemic influenza H5N1 vaccine

April 3, 2008

Relistor receives Canadian approval for opioid-induced constipation

April 2, 2008

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 11, 2026.
First measles treatment advances as vaccination rates drop
BioWorld
Scientists at the La Jolla Institute for Immunology have identified and characterized human antibodies that neutralize the measles virus by blocking its entry...
Hantavirus is ‘sentinel’ more than acute pandemic threat
BioWorld
News of eight infections and three deaths so far due to an emerging zoonotic virus has brought back unhappy memories of the early days of SARS-CoV-2. At a press...
Infensa Bioscience identifies new ASIC blockers
BioWorld Science
Infensa Bioscience Pty Ltd. has patented new acid-sensing ion channel 1 (ASIC) blockers potentially useful for the treatment of stroke, among others.
Italy’s Angelini pays $4.1B cash for rare disease specialist Catalyst
BioWorld
Italian family-owned Angelini Pharma SpA is making its first move into the U.S. market, acquiring rare diseases specialist Catalyst Pharma Inc. in an all-cash...